Evidence map›Paper›PMID 38695137›Full record

ArticleHaematologica2024

CD22-targeted glyco-engineered natural killer cells offer a further treatment option for B-cell acute lymphoblastic leukemia.

Xin Jin, Rui Sun, Zhu Li, Xianwu Wang, Xia Xiong, Wenyi Lu, Hairong Lyu, Xia Xiao, Yunpeng Tian, Hongkai Zhang and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xin JinDepartment of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, China; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121. jxin00@126.com.
Rui SunDepartment of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, China; School of Medicine, Nankai University, Tianjin, 300071.
Zhu LiInstitute of Ocean Research, Ningbo Institute of Marine Medicine, Peking University, Beijing, 100191. lizhu.china@163.com.
Xianwu WangXiamen Nuokangde Biological Technology Co., Ltd, Xiamen, 361006.
Xia XiongDepartment of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192.
Wenyi LuDepartment of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192.
Hairong LyuDepartment of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192.
Xia XiaoDepartment of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192.
Yunpeng TianXiamen Nuokangde Biological Technology Co., Ltd, Xiamen, 361006.
Hongkai ZhangState Key Laboratory of Medicinal Chemical Biology and College of Life Science, Nankai University, Tianjin, 300350.
Zhihong FangDepartment of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361102. jeho_fang@126.com.
Luqiao WangDepartment of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016. luqiaowang@126.com.
Mingfeng ZhaoDepartment of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, 300192, China; School of Medicine, Nankai University, Tianjin, 300071. mingfengzhao@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Killer Cells, NaturalPrecursor B-Cell Lymphoblastic Leukemia-LymphomaSialic Acid Binding Ig-like Lectin 2HumansImmunotherapy, AdoptiveCD22 protein, humanSialic Acid Binding Ig-like Lectin 2

Identifiers

PMID38695137
PMCPMC11367193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.